Faster method to create antibodies for disease researchOctober 07, 2005Faster method to create antibodies for disease research British scientists are pioneering a new technique to produce large numbers of antibodies quickly and reliably to help the study of dangerous bacteria. The research, funded by the Biotechnology and Biological Sciences Research Council (BBSRC), is a critical area for study as bacteria such as streptococcus cause deadly blood infections and 'flesh eating bug disease'. Traditional methods of producing antibodies for research are slow and laborious and pose a significant bottleneck to proteomics research as they can take months of effort. This research offers a potential solution that could produce antibodies in just weeks. Antibodies are vital to the study of proteins as they can bind specifically to a protein of interest and enable researchers to identify, count and track the protein in vitro and in vivo. The study of proteins is important to almost every area of biology as they are often the targets for vaccines, the raw materials for bioprocessing or are employed as environmental biomarkers. The researchers from Imperial College London at Hammersmith Hospital discovered that a large proportion of antibodies created in response to synthetic peptide immunisation bind to the end of a peptide known as the C-terminus. The unique way that it is presented means that the antibodies will only bind to proteins that contain a precise sequence in their C-terminus. Dr Rob Edwards, the research leader at Imperial College London, said, "The fact that the antibodies only bind to proteins with the specific sequence in their C-terminus means they are incredibly specific. We started looking at antibodies raised against simple peptide chains comprising just 5 amino acid residues and found that every one these bound only to the target protein." Dr Edwards commented, "New research in proteomics has already identified thousands of proteins that may be important. We need to be able to study them at a higher rate than we can currently. This new method is a simple way of creating libraries of specifically binding antibodies to aid in such studies. To demonstrate the application of the method we have produced antibodies against a group of bacterial proteins in just a few weeks. Using traditional methods this would have taken several years." Dr Edwards is proving the effectiveness of the new technique through an existing collaboration with Dr Shiranee Sriskandan at Imperial College London to characterise novel proteins produced by Streptococcus pyogenes. By creating specific antibodies to S. pyogenes virulence factors the scientists are taking the first step in developing drugs and vaccines against the organism. Biotechnology and Biological Sciences Research Cou |
|||||||||||||||||||||
| Related Antibodies Current Events and Antibodies News Articles Gene mismatch influences success of bone marrow transplants A commonly inherited gene deletion can increase the likelihood of immune complications following bone marrow transplantation, an international team of researchers reports in the November 22 advance online issue of Nature Genetics. New cancer target for non-Hodgkin's lymphoma Physician-scientists from Weill Cornell Medical College have discovered a molecular mechanism that may prove to be a powerful target for the treatment of non-Hodgkin's lymphoma, a type of cancer that affects lymphocytes, or white blood cells. On the Trail of a Vaccine for Lyme Disease: Yale Researchers Target Tick Saliva A protein found in the saliva of ticks helps protect mice from developing Lyme disease, Yale researchers have discovered. The findings, published in the November 19 issue of Cell Host & Microbe, may spur development of a new vaccine against infection from Lyme disease, which is spread through tick bites. New findings suggest strategy to help generate HIV-neutralizing antibodies New discoveries about anti-HIV antibodies may bring researchers a step closer to creating an effective HIV vaccine, according to a new paper co-authored by scientists at the Vaccine Research Center of the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health. Sweet -- sugared polymer a new weapon against allergies and asthma Scientists at Johns Hopkins and their colleagues have developed sugar-coated polymer strands that selectively kill off cells involved in triggering aggressive allergy and asthma attacks. Largest gene study of childhood IBD identifies 5 new genes In the largest, most comprehensive genetic analysis of childhood-onset inflammatory bowel disease (IBD), an international research team has identified five new gene regions, including one involved in a biological pathway that helps drive the painful inflammation of the digestive tract that characterizes the disease. People with less education could be more susceptible to the flu People who did not earn a high school diploma could be more likely to get H1N1 and the vaccine might be less effective in them compared to those who earned a diploma, new research shows. Exposure to several common infections over time may be associated with risk of stroke Cumulative exposure to five common infection-causing pathogens may be associated with an increased risk of stroke, according to a report posted online today that will appear in the January 2010 print issue of Archives of Neurology, one of the JAMA/Archives journals. Scientists explain binding action of 2 key HIV antibodies; could lead to new vaccine design A very close and detailed study of how the most robust antibodies work to block the HIV virus as it seeks entry into healthy cells has revealed a new direction for researchers hoping to design an effective vaccine. New Synthetic Molecules Trigger Immune Response to HIV and Prostate Cancer Researchers at Yale University have developed synthetic molecules capable of enhancing the body's immune response to HIV and HIV-infected cells, as well as to prostate cancer cells. Their findings, published online in the Journal of the American Chemical Society, could lead to novel therapeutic approaches for these diseases. More Antibodies Current Events and Antibodies News Articles |
|||||||||||||||||||||
|
|||||||||||||||||||||
|
|||||||||||||||||||||